NEW YORK, July 9 - Celera Genomics and the National Cancer Institute have entered into an agreement of understanding for NCI's use of Celera's databases, the organizations announced Monday.

The signed memorandum of understanding outlines the terms and conditions for individual NCI investigators to choose to purchase access to Celera's Discovery System, including analytical tools and databases such as the fruit fly, human, and mouse genomes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.